Stay updated with breaking news from Colin Kleanthous. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Glox Therapeutics, a company developing precision antibiotic therapies, has raised £4.3 million in seed funding to develop effective targeted ther...
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
People who lost money for care home fees and others facing rocketing mortgage costs after Truss’s gambit share their stories
A new study published in the journal Science Advances sheds light on how Gram-negative bacteria like E. coli construct their outer membrane to resemble body armor, which has far-reaching implications for the development of antibiotics.
A new study published in Nature today has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.